|
|
|
|
Asset-Backed Securities (continued)
|
Cedar Funding XIV CLO Ltd., Series 2021-14A, Class A,
(3-mo. CME Term SOFR + 1.36%), 6.66%,
07/15/33(a)(b)
|
|
|
|
|
|
|
|
Series 2013-2A, Class A3LR, (3-mo. CME Term
SOFR + 2.21%), 7.49%, 10/18/30
|
|
|
|
Series 2015-4A, Class A1A2, (3-mo. CME Term
SOFR + 1.33%), 6.61%, 04/20/34
|
|
|
|
Series 2018-1A, Class C, (3-mo. CME Term SOFR +
2.01%), 7.29%, 04/18/31
|
|
|
|
Series 2018-1A, Class D, (3-mo. CME Term SOFR +
2.91%), 8.19%, 04/18/31
|
|
|
|
Series 2019-2A, Class BR, (3-mo. CME Term SOFR
+ 1.76%), 7.05%, 04/17/34
|
|
|
|
Series 2019-5A, Class A2RS, (3-mo. CME Term
SOFR + 2.01%), 7.31%, 01/15/35
|
|
|
|
Series 2020-2A, Class AR, (3-mo. CME Term SOFR
+ 1.43%), 6.71%, 10/20/34
|
|
|
|
Series 2020-3A, Class A1R, (3-mo. CME Term SOFR
+ 1.39%), 6.67%, 10/20/34
|
|
|
|
Series 2021-1AR, Class A1R, (3-mo. CME Term
SOFR + 1.42%), 6.76%, 07/25/37
|
|
|
|
|
|
|
|
Series 2018-1A, Class A1RR, (3-mo. CME Term
SOFR + 1.53%), 6.85%, 04/20/37
|
|
|
|
Series 2021-1A, Class A, (3-mo. CME Term SOFR +
1.36%), 6.64%, 04/22/34
|
|
|
|
Series 2021-2A, Class B, (3-mo. CME Term SOFR +
2.01%), 7.29%, 07/20/34
|
|
|
|
Clover CLO Ltd., Series 2019-2A, Class AR, (3-mo.
CME Term SOFR + 1.36%), 6.65%, 10/25/33(a)(b)
|
|
|
|
Diameter Capital CLO Ltd., Series 2021-1A, Class A1A,
(3-mo. CME Term SOFR + 1.50%), 6.80%,
07/15/36(a)(b)
|
|
|
|
Dryden CLO Ltd., Series 2020-77A, Class AR, (3-mo.
CME Term SOFR + 1.38%), 6.51%, 05/20/34(a)(b)
|
|
|
|
Elmwood CLO 15 Ltd., Series 2022-2A, Class A1, (3-
mo. CME Term SOFR + 1.34%), 6.62%,
04/22/35(a)(b)
|
|
|
|
Elmwood CLO 26 Ltd, Series 2026-1A, Class C, (3-mo.
CME Term SOFR + 2.40%), 7.69%, 04/18/37(a)(b)
|
|
|
|
Elmwood CLO II Ltd., Series 2019-2A, Class AR, (3-mo.
CME Term SOFR + 1.41%), 6.69%, 04/20/34(a)(b)
|
|
|
|
Elmwood CLO VII Ltd.(a)(b)
|
|
|
|
Series 2020-4A, Class A1RR, 10/17/37(c)
|
|
|
|
Series 2020-4A, Class AR, (3-mo. CME Term SOFR
+ 1.63%), 6.92%, 01/17/34
|
|
|
|
Elmwood CLO XI Ltd., Series 2021-4A, Class B, (3-mo.
CME Term SOFR + 1.86%), 7.14%, 10/20/34(a)(b)
|
|
|
|
Elmwood CLO XII Ltd.(a)(b)
|
|
|
|
Series 2019-2A, Class B, (3-mo. CME Term SOFR +
1.96%), 7.24%, 01/20/35
|
|
|
|
Series 2021-5A, Class BR, 10/20/37(c)
|
|
|
|
Galaxy XX CLO Ltd., Series 2015-20A, Class D1R, (3-
mo. CME Term SOFR + 2.86%), 8.14%,
04/20/31(a)(b)
|
|
|
|
Generate CLO Ltd., Series 6A, Class DR, (3-mo. CME
Term SOFR + 1.46%), 6.74%, 01/22/35(a)(b)
|
|
|
|
Golub Capital Partners CLO Ltd.(a)(b)
|
|
|
|
Series 2019-41A, Class AR, (3-mo. CME Term SOFR
+ 1.58%), 6.86%, 01/20/34
|
|
|
|
Series 2021-53A, Class B, (3-mo. CME Term SOFR +
2.06%), 7.34%, 07/20/34
|
|
|
|